| Product Code: ETC10765591 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of pemetrexed to Cyprus in 2024 saw significant contributions from Greece, Germany, Netherlands, Switzerland, and Vietnam. With a moderate concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market remains competitive. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a robust 10.34%, demonstrating a steady increase in demand. Moreover, the growth rate from 2023 to 2024 spiked to 13.05%, indicating a promising outlook for the pemetrexed market in Cyprus.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Pemetrexed Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Pemetrexed Market - Industry Life Cycle |
3.4 Cyprus Pemetrexed Market - Porter's Five Forces |
3.5 Cyprus Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Cyprus Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Cyprus Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Cyprus Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Cyprus Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Cyprus Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Pemetrexed Market Trends |
6 Cyprus Pemetrexed Market, By Types |
6.1 Cyprus Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Cyprus Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Cyprus Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Cyprus Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Cyprus Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Cyprus Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Cyprus Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Cyprus Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Cyprus Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Cyprus Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Cyprus Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Cyprus Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Cyprus Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Cyprus Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Cyprus Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Cyprus Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Cyprus Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Cyprus Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Cyprus Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Cyprus Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Cyprus Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Cyprus Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Cyprus Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Cyprus Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Cyprus Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Cyprus Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Cyprus Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Cyprus Pemetrexed Market Import-Export Trade Statistics |
7.1 Cyprus Pemetrexed Market Export to Major Countries |
7.2 Cyprus Pemetrexed Market Imports from Major Countries |
8 Cyprus Pemetrexed Market Key Performance Indicators |
9 Cyprus Pemetrexed Market - Opportunity Assessment |
9.1 Cyprus Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Cyprus Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Cyprus Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Cyprus Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Cyprus Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Cyprus Pemetrexed Market - Competitive Landscape |
10.1 Cyprus Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here